Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

ConclusionThis study suggests that buffered soluble ALN represents a cost-effective strategy compared with relevant alternative treatments for postmenopausal osteoporosis women in Italy aged 60 years and over.

http://link.springer.com/10.1007/s00198-020-05802-5

Source: Osteoporosis International - January 14, 2021 Category: Orthopaedics Source Type: research